Literature DB >> 22594473

Targeting cancer stem cells with natural products.

Joseph Burnett1, Bryan Newman, Duxin Sun.   

Abstract

The cancer stem cell (CSC) hypothesis presents a fundamentally different paradigm for cancer treatment. CSCs reflect a small fraction of tumor initiating cells capable of sustained self-renewal and differentiation to form the heterogeneous tumor bulk. In order to cure cancer, it is necessary to eliminate cancer stem cells in addition to differentiated cancer cells to decrease metastasis, reduce recurrence, and improve patient survival. In this article, we review cancer stem cell signaling pathways, including Wnt, Hedgehog, and Notch, as well as interactions of CSCs with the tumor microenvironment. We also review methods to isolate CSCs and demonstrate therapeutic efficacy of natural products to modulate these signaling pathways for eliminating CSCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22594473     DOI: 10.2174/138945012802009062

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  13 in total

1.  (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.

Authors:  Ya-Jun Li; Shun-Long Wu; Song-Mei Lu; Fang Chen; Ying Guo; Sheng-Min Gan; Yan-Long Shi; Shuang Liu; Shao-Lin Li
Journal:  Tumour Biol       Date:  2014-12-07

2.  EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation.

Authors:  Chien-Hung Lin; Li-Keng Chao; Peir-Haur Hung; Yann-Jang Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

3.  The fruits of Maclura pomifera extracts inhibits glioma stem-like cell growth and invasion.

Authors:  Dan Zhao; Chengyun Yao; Xiaobing Chen; Hongping Xia; Li Zhang; Huixiang Liu; Xiaochun Jiang; Yi Dai; Jun Liu
Journal:  Neurochem Res       Date:  2013-08-09       Impact factor: 3.996

4.  Gamma tocotrienol targets tyrosine phosphatase SHP2 in mammospheres resulting in cell death through RAS/ERK pathway.

Authors:  Wenyi Gu; Indira Prasadam; Meihua Yu; Fengxia Zhang; Patrick Ling; Yin Xiao; Chengzhong Yu
Journal:  BMC Cancer       Date:  2015-08-28       Impact factor: 4.430

5.  Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy.

Authors:  Christopher C Pan; Nirav Shah; Sanjay Kumar; Sarah E Wheeler; Jason Cinti; Dale G Hoyt; Christine E Beattie; Min An; Karthikeyan Mythreye; L Harinantenaina Rakotondraibe; Nam Y Lee
Journal:  Oncotarget       Date:  2017-02-21

Review 6.  Anti-Cancer Phytometabolites Targeting Cancer Stem Cells.

Authors:  Heron F V Torquato; Márcia I Goettert; Giselle Z Justo; Edgar J Paredes-Gamero
Journal:  Curr Genomics       Date:  2017-04       Impact factor: 2.236

7.  Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines.

Authors:  Chien-Hung Lin; Yao-An Shen; Peir-Haur Hung; Yuan-Bin Yu; Yann-Jang Chen
Journal:  BMC Complement Altern Med       Date:  2012-10-30       Impact factor: 3.659

Review 8.  Salinomycin as a drug for targeting human cancer stem cells.

Authors:  Cord Naujokat; Roman Steinhart
Journal:  J Biomed Biotechnol       Date:  2012-11-21

9.  Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines.

Authors:  Puteri Baharuddin; Nazilah Satar; Kamal Shaik Fakiruddin; Norashikin Zakaria; Moon Nian Lim; Narazah Mohd Yusoff; Zubaidah Zakaria; Badrul Hisham Yahaya
Journal:  Oncol Rep       Date:  2015-11-02       Impact factor: 3.906

10.  Anticancer bioactive peptide-3 inhibits human gastric cancer growth by targeting miR-338-5p.

Authors:  Zhiwei Xing; Lan Yu; Xian Li; Xiulan Su
Journal:  Cell Biosci       Date:  2016-09-22       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.